Abstract Ahnak1, a giant 700 kDa protein, has been implicated in Ca 2+ signalling in various cells. Previous work suggested that the interaction between ahnak1 and Cavβ 2 subunit plays a role in L-type Ca 2+ current (I CaL ) regulation. Here, we performed structure-function studies with the most C-terminal domain of ahnak1 (188 amino acids) containing a PxxP consensus motif (designated as 188-PSTP) using ventricular cardiomyocytes isolated from rats, wild-type (WT) mice and ahnak1-deficient mice. In vitro binding studies revealed that 188-PSTP conferred high-affinity binding to Cavβ 2 (K d ∼60 nM). Replacement of proline residues by alanines (188-ASTA) decreased Cavβ 2 affinity about 20-fold. Both 188-PSTP and 188-ASTA were functional in ahnak1-expressing rat and mouse cardiomyocytes during whole-cell patch clamp. Upon intracellular application, they increased the net Ca 2+ influx by enhancing I CaL density and/or increasing I CaL inactivation time course without altering voltage dependency. Specifically, 188-ASTA, which failed to affect I CaL density, markedly slowed I CaL inactivation resulting in a 50-70% increase in transported Ca 2+ during a 0 mV depolarising pulse. Both ahnak1 fragments also slowed current inactivation with Ba 2+ as charge carrier. By contrast, neither 188-PSTP nor 188-ASTA affected any I CaL characteristics in ahnak1-deficient mouse cardiomyocytes. Our results indicate that the presence of endogenous ahnak1 is required for tuning the voltagedependent component of I CaL inactivation by ahnak1 fragments. We suggest that ahnak1 modulates the accessibility of molecular determinants in Cavβ 2 and/or scaffolds selectively different β-subunit isoforms in the heart.
Introduction
Ahnak1 is a large protein of ∼700 kDa implicated in many fundamental biological processes, such as Ca 2+ signalling, plasma membrane repair, exocytosis and blood-brain barrier function [1, 17, 26, 27, 33, 34, 36, 40] . It was originally identified in human neuroblastoma cells [44] and skin epithelial cells [23] . Ahnak1 is abundantly expressed in muscle cells where it locates to the inner side of the plasma membrane [15, 25] . The ahnak1 protein contains three main Electronic supplementary material The online version of this article (doi:10.1007/s00424-010-0853-x) contains supplementary material, which is available to authorized users. structural regions: a relatively short globular N-terminus, a large central region of ∼4,300 amino acids consisting of multiple repeated units and the C-terminal ∼1,000 amino acids [44] .
Given ahnak's role as scaffolding and signalling molecule, one would expect that targeted ablation of ahnak1 results in a severe phenotype. However, ahnak1-deficient mice are fertile and have a normal life span, suggesting that ahnak1 is redundant in this model [31, 32] . Komuro et al. [31] proposed ahnak2 as candidate to compensate for the loss of function of ahnak1. Ahnak2 is also a large protein with a typical central repeat structure. The repeating units of ahnak1 and ahnak2 share homology while the N-terminal and C-terminal regions show no similarities. Notably, the C-terminus of ahnak1 harbours a PxxP consensus motif known as potential interaction partner for sarc homology 3 (SH3) domaincontaining proteins [38] .
Ahnak1 belongs to the increasing number of intracellular proteins interacting with the Cavβ subunit of voltagedependent Ca 2+ channels [30] . We previously showed that ahnak1 binds to the β 2 -subunit of cardiac Cav1.2 channels and modulates the L-type Ca 2+ current (I CaL ) in rat cardiomyocytes [2, 18, 25] . In fact, the most C-terminal region of ahnak1 encompassing 188 amino acids emerged as a potent modulator of I CaL . Intracellular application of this fragment during whole-cell patch clamp increased I CaL density and slowed its inactivation time course [2] . As a working hypothesis, we suggested that a certain portion of β 2 -subunits is functionally masked by ahnak1 and can be relieved by competition with ahnak1-derived peptides. This mechanism would result in an enhanced I CaL as β-subunits are generally known to increase channel open probability besides their role in addressing α 1C to the sarcolemma [11] . However, less is known to account for the slower inactivation kinetics following ahnak peptide application. A peptide competition mechanism could solely account for this effect if β 2 -subunit isoforms are relieved (are more available), which slow channel inactivation like the lipidmodified β 2a isoform [39] . But this isoform is not believed to constitute the functional type of β 2 -subunit in rat heart [28, 46, 47] .
In general, β-subunits belong to the protein family of membrane-associated guanylate kinases (MAGUK) comprising an SH3 and guanylate kinase (GK) element. It has been reported that in β-subunits the SH3 and GK elements form a functional important module that supports I CaL and regulates channel inactivation [37] . Thus, an alternative mechanism underlying slowing I CaL inactivation can be envisioned if the C-terminal ahnak1 peptides applied through the patch pipette would directly bind to β 2 -subunits or any other sites thereby influencing I CaL gating. One can assume that the latter mode of action operates also in ahnak1-deficient cardiomyocytes.
In the present study, we demonstrate that ahnak1 fragments failed to affect I CaL in ahnak1-deficient cardiomyocytes while they evoked an increase in Ca 2+ entry in wild-type (WT) rodent cardiomyocytes preferentially by slowing I CaL inactivation time course. Thus, ahnak1 plays a nonredundant role in L-type Ca 2+ channel inactivation and provides a mechanism for tuning Ca 2+ channel activity in the heart.
Materials and methods

Recombinant proteins
The GST-tagged β 2 -subunit (CaB2a, Oryctolagus cuniculus, NCBI entry name gi|1498) was expressed and purified as described [25] . The GST fusion protein containing the 188 C-terminal amino acids of ahnak1 (188-PSTP, previously designated as P3P4) was prepared as in Alvarez et al. [2] . The proline residues corresponding to amino acid positions 5592 and 5595 in ahnak1 (accession number NP_001611) were substituted by alanine using the QuickChange sitedirected mutagenesis kit (StratageneEurope, Amsterdam, Netherlands) to yield 188-ASTA. The GST fusion proteins containing the intracellular loops connecting domains I-II and II-III of the rabbit cardiac α 1C were expressed and purified using standard protocols. The pGEX constructs for these α 1C -containing fusion proteins were kindly provided by Dr. Nathan Dascal (Tel Aviv, Israel). All constructs were checked by restriction site mapping and sequencing.
Analytical ultracentrifugation
Equilibrium-binding studies were performed in a XL-Atype analytical ultracentrifuge (Beckman, Palo Alto, CA, USA) equipped with ultraviolet (UV) absorbance optics as in Hohaus et al. [25] . For data analysis, the program POLYMOLE was used [4] .
SPR binding
The purified recombinant proteins 188-PSTP and 188-ASTA were immobilised on a CM5 sensor chip (GE Healthcare, Uppsala, Sweden) at parallel flow cells by amine coupling according to manufacturer's instructions. Tissue sampling A cohort of male ahnak1-deficient mice in a C57BL6/J genetic background and their WT controls were studied at 6 months of age if not stated otherwise. The generation of homozygous ahnak1-deficient mice was described in Kouno et al. [32] . Mice do not present any obvious abnormalities. They were maintained in a temperaturecontrolled environment with free access to standard laboratory chow and tap water in the animal facility of the Max Delbrück Center (Berlin, Germany). For cardiomyocytes preparations, the animals were anaesthetised with isoflurane followed by intraperitoneal injection of 8 µg xylazine and 35 µg ketamine. The hearts were rapidly removed and processed as outlined below. Experiments were approved by the Berlin federal region's institutional animal care body (LAGeSo T 0088/99).
Electrophysiological measurements
Ventricular myocytes were isolated from adult male Wistar rats (200-300 g), from 6-month-old male ahnak1-deficient mice and the respective WT littermates as in Alvarez et al. [2] . The standard Tyrode solution was (mM): 117 NaCl, 4 KCl, 1.5 KH 2 PO 4 , 4.4 NaHCO 3 , 1.7 MgCl 2 , 10 HEPES, 10 glucose, pH 7.4. Collagenase (Worthington-type CLS 2) was added at 0.8 mg ml -1 . The freshly dissociated cells were kept in the physiological solution with 1 mM Ca 2+ and 0.5% bovine serum albumin at room temperature and used within 6-8 h. L-type Ca 2+ current (I CaL ) was recorded using the "whole-cell" variant of the patch clamp method at room temperature (22±2°C). 188-PSTP and 188-ASTA were directly dissolved in the pipette "intracellular" solution. Pipette tips were first immersed in the normal intracellular solution for at least 1 min and then back filled with the intracellular solution containing the desired ahnak1 fragment. After gigaseal formation and rupture of the patch, cells were let to stabilise for at least 5 min before beginning the recordings. Ca 2+ current density values were obtained after at least 10 min perfusion. Results were analysed by the Student's t test and are expressed as means ± SEM, * with p < 0.05. Further experimental details are given in supplemental material.
Heart tissue preparations
Tissue homogenates were prepared from frozen ventricular samples (100 mg) with 800 µl homogenisation buffer consisting of (mM): 50 HEPES, 150 NaCl, 50 Na 2 HPO 4 , 25 NaF, 10 EDTA, 0.2 DTT and protease inhibitor cocktails (Sigma P8340, Roche). The samples were first homogenised with a glass-teflon pestle and then with a Polytron PT 10-35 instrument at 10.000 rpm for 3×5 s. The cytosolic fraction was prepared by high-speed centrifugation (2 h at 100.000×g) of the homogenates. Cardiac membrane fractions were prepared according to Karczewski et al. [29] . Briefly, ventricular tissue (100 mg) was homogenised twice with a KCl-containing (0.75 M) buffer to remove myofibrils followed by low salt buffer including protease inhibitors as above.
Pull down of endogenous β 2 -subunits
The GST fusion protein containing the intracellular loop connecting domain I-II of the rabbit cardiac α 1C (2.5 µg) was bound to glutathione-sepharose (5 µl packed gel) in a final volume of 1 ml buffer A consisting of 50 mM Tris, 150 mM NaCl, 0.2% Triton X-100, 0.2% CHAPS and protease inhibitor cocktails (Sigma P8340, Roche), pH 7.4 for 1 h at 4°C on a rotating wheel. For control experiments, the equimolar concentration of unfused GST protein was coupled under the same conditions. Cytosolic fractions prepared from mouse and rat hearts (100 µg) were diluted with buffer A to a final volume of 1 ml and incubated with either α 1C I-II loop affinity beads or GST control beads for 2 h at 4°C. The beads were washed 3 times with 0.5 ml of buffer A for 5 min at 4°C, subsequently suspended in 60 µl sodium dodecyl sulfate (SDS) sample buffer, and incubated for 3 min at 95°C.
Western blot analyses
For ahnak1 detection, protein samples were separated on 6.5% SDS polyacrylamide gels and transferred to nitrocellulose for 2 h at 300 mA. For α 1C -and β 2 -subunit detection, the protein samples were separated on 8% SDS polyacrylamide gels and transferred for 90 min at 210 mA. The transfers were incubated with affinitypurified antibodies (1 µg IgG ml -1 anti-ahnak1, 0.5 µg IgG ml -1 anti-α 1C , 0.25 µg IgG ml -1 anti-β 2 ) followed by the peroxidase-coupled anti-rabbit IgG (dilution 1:100,000, Pierce, Rockford, IL, USA). Immunoreactive protein bands were visualised by the enhanced chemiluminescence (ECL) reaction (Millipore). The anti-ahnak1 antibody was produced against the head portion of ahnak1 as in Hohaus et al. [25] . The antigenic epitopes for anti-α 1 C and anti-β 2 antibodies comprised (EEEEKERKKLARTASPEKK) and (EWNRDVYIRQ), respectively [20, 41] .
Results
The C-terminal PxxP motif in ahnak1 is important for high-affinity β 2 -subunit binding
The 5592-PSTP-5595 sequence in the C-terminal region of ahnak1 constitutes a PxxP consensus motif known to be important for protein-protein interaction [38] . To study whether this motif plays a role for β 2 -subunit interaction, we replaced the proline residues by alanine in a recombinant protein derived from ahnak1 encompassing the most C-terminal 188 amino acids and performed in vitro binding studies. The ahnak1-derived proteins were designated as 188-PSTP and 188-ASTA, respectively, throughout this study. Equilibrium-binding experiments summarised in Fig. 1a revealed remarkable differences in β 2 -subunit binding. 188-PSTP displayed two-site β 2 -subunit interaction with K d values of 60±20 nM (n=4) and 300±100 nM (n=4) for high-and low-affinity sites, respectively. By contrast, 188-ASTA revealed a single population of binding sites with a K d value of 1.2±0.8 µM (n=8).
Next, we studied protein-protein interaction within a minute time scale by SPR spectroscopy. For these experiments, 188-PSTP and 188-ASTA were covalently bound at neighbouring lanes of a CM-5 biosensor chip at low ligand concentrations (700 RU corresponding to 0.7 ng mm -2 ). Subsequently, the chip was superfused with different concentrations of recombinant β 2 -subunit followed by running buffer. Typical sensorgrams shown in Fig. 1b illustrate that the β 2 -subunit associates rapidly to both C-terminal ahnak1 fragments and dissociates slowly. The slow dissociation rates (particularly for 188-PSTP) observed in the concentration range tested (2 µM to 5 µM β 2 -subunit) prevented the calculation of the K d values from kinetic data (K d =k off /k on ). But the association rate constants could well be estimated amounting to 2,100±300 M -1 s -1 (n=8) and 2,400±200 M -1 s -1 (n=8) for 188-PSTP and 188-ASTA, respectively. Together, the binding experiments prompted us to study in vivo effects of these C-terminal ahnak1 fragments on cardiomyocytes.
Effects of 188-PSTP and 188-ASTA on Ca 2+ currents of rat ventricular cardiomyocytes Given the critical role of PSTP for β 2 -subunit binding, we reasoned that 188-ASTA would be less efficient in I CaL modulation due to its lower affinity for the β 2 -subunit. To address this question, we applied 100 nM of one or the other ahnak1-fusion proteins to ventricular rat cardiomyocytes under patch clamp conditions. This concentration is well over the K d value of the high-affinity interaction site of the 188-PSTP/β 2 complex, but below the K d value of the 188-ASTA/β 2 complex. Indeed, original traces depicted in Fig. 2a illustrate that under these conditions 188-PSTP was sufficient to increase current amplitude by about 20% (from 10.8±0.6 to 12.9±0.8 pA/pF) and to prolong channel inactivation time course by significantly increasing the fast time constant, τ fast (from 4.7±02 to 5.5±0.4 ms), leaving n Number of cells from at least three animals * p<0.05 with respect to its respective control; ** p < 0.05 with respect to Ca b Voltage dependency of the inactivation time constants τ fast and τ slow in the same experimental conditions. Note that at -20 mV, the currents were fitted by only one inactivation time constant. n = 12 Control, 6 PSTP or 6 ASTA from at least four hearts. * p<0.05 with respect to control the slow component, τ slow , unaffected, whereas 188-ASTA had no effect on I CaL (data not shown). However, higher concentrations of 188-ASTA were functional. Figure 2b demonstrates an example for the application of 5 µM 188-ASTA (well over K d ), which led to a marked prolongation of the I CaL inactivation time course by increasing both inactivation time constants τ fast and τ slow while peak current density remained unaffected. The increase in τ fast by 100 nM 188-PSTP and the increases in both τ fast and τ slow by 5 µM 188-ASTA were not voltage-dependent as they occurred at all imposed membrane potentials (Fig. 2c) . No voltage-dependent shifts were observed on I CaL -V and availability curves (data not shown). Together, although 188-PSTP and 188-ASTA affected I CaL differently, they led to a marked increase in the amount of transported charges (Q Ca2+ ) during a 200 ms depolarisation to 0 mV (Fig. 2a, B,  insets) . When 188-PSTP and 188-ASTA were both applied at 10 µM, they increased Q Ca2+ by 59% and 78%, respectively (Table 1) .
Changes in τ fast have been commonly associated to the Ca 2+ -dependent inactivation (CDI) mechanism. Hence, we asked whether the ahnak1 fragments are also functional when using Ba 2+ as charge carrier. The results are summarised in Fig. 3 and Table 1 . Under control conditions in the presence of Ba 2+ , peak inward current I BaL was increased (≅60%) and inactivation time course markedly prolonged, as known. In the presence of 10 µM 188-PSTP or 188-ASTA, I BaL inactivation time constants were significantly increased to very similar extent, while peak I BaL was unaffected. The rise in τ fast and τ slow elicited by the ahnak1 fragments was not voltage-dependent (Fig. 3b) .
Effects of 188-PSTP and 188-ASTA on Ca 2+ currents of mouse cardiomyocytes
To further understand the role of ahnak1 in Ca 2+ current modulation, potential effects of the ahnak1 fragments on ahnak1-deficient (KO) cardiomyocytes were studied. We first examined the phenotype of ventricular myocytes isolated from KO mice. Western blot analysis confirmed ahnak1 deficiency in KO myocytes (Fig. 4a) . Cardiomyocytes isolated from KO were shorter than those isolated from WT littermates (132.6 ± 1.8 µm, n = 135 and 155.8 ± 2.2 µm, n = 155; in ahnak1-KO and WT, respectively). They showed regular cross-striation with similar mean resting sarcomere lengths (Fig. 4b) . In line with the reduced cell length, membrane capacitance values were significantly lower in KO myocytes (Table 2) . KO cardiomyocytes displayed a lower I CaL density at all investigated voltages (Fig. 5a , Table 2 ). In addition, τ fast was significantly smaller while τ slow was not altered. Consequently, Q Ca2+ was smaller in ahnak1-deficient cardiomyocytes than in WT ones (Table 2) . However, the activation and availability curves for the two cell types had similar slope factor and voltage dependency as was suggested by the shape of I-V curves ( Table 2) . Fig. 4 Phenotype of ahnak1-deficient cardiomyocytes. a Total cardiac tissue lysates from WT and ahnak1-deficient mice (Ahnak1-KO) were subjected to SDS-polyacrylamide gel electrophoresis (PAGE) and Western blot analyses using an affinity-purified antibody generated against the head portion of ahnak1. The lower panel shows the Coomassie-stained myosin heavy chain (MyHC) as loading control. b Phase contrast images of representative cardiomyocytes isolated from 6-month-old WT and ahnak1-deficient mice Intracellular dialysis of WT cardiomyocytes with 10 µM 188-PSTP resulted in a 4-5 ms statistically significant increase in τ fast of I CaL while τ slow and I CaL density were not affected (Fig. 6a, c) . These effects of 188-PSTP represented a significant increase in Q Ca2+ from 0.33±0.04 pC/pF to 0.41±0.03 pC/pF. No changes were observed in I-V, activation and availability curves (data not shown). By contrast, intracellular dialysis of KO cardiomyocytes with 10 µM 188-PSTP had no effect on any I CaL characteristics (Fig. 6c, d ).
In the next set of patch clamp experiments, we investigated the effects of 10 µM 188-ASTA in WT mouse cardiomyocytes. 188-ASTA significantly increased both τ fast and τ slow in a voltage-independent fashion, leaving peak I CaL unchanged (Fig. 7a, c) . This resulted in a significant increase in Q Ca2+ from 0.39±0.01 pC/pF to 0.58±0.04 pC/pF. Besides, intracellular dialysis of KO cardiomyocytes with 10 µM ASTA had no effects on any I CaL characteristics (Fig. 7b, d ). Taken together, the Cterminal ahnak1 fragments require the presence of endogenous ahnak1 to affect I CaL inactivation.
Ca
2+ channel subunit expression in the cardiac models
We asked whether the differences in I CaL gating and modulation between ahnak1-KO and WT cardiomyocytes could be due to different expression levels of Ca 2+ channel subunits. Western blot analyses on cardiac membrane preparations revealed similar α 1C and β 2 protein levels in both strains (Fig. 8a, b) . Using recombinant proteins for calibration (Fig. 8a, b , right panels), expression levels of ∼2 and ∼60 pmoles per mg of membrane protein were calculated for the endogenous L-type Ca 2+ channel subunits α 1C and β 2 , respectively (Table 3) .
Next, we compared β 2 -subunit expression in the two rodent models used for patch clamp experiments. Consistent with previous reports [19] [20] [21] , the prominent β 2 -band migrated at 80 kDa in mouse and rat hearts. An additional faint β 2 -signal was visible at 95 kDa in the rat. This band was more prominent in the cytosolic fraction and bound strongly to the α 1C I-II loop (Fig. 8c) . The latter finding defines the 95 kDa protein reliably as β 2 -subunit isoform. Thus, species-specific differences were observed in isoform pattern and with respect to the distribution between membrane-bound and cytosolic β 2 -subunits (Table 3 ).
Discussion
Our results show that upon intracellular delivery, the C-terminal ahnak1 fragments 188-PSTP and 188-ASTA enhance Ca 2+ entry in non-transgenic rodent cardiomyocytes, mostly by slowing I CaL inactivation. This gain-of-function effect was not observed in ahnak1-deficient cardiomyocytes. The data strongly suggest that ahnak1/Cavβ 2 complexes of control myocytes are targeted by ahnak1 fragments and imply that ahnak1 scaffolds different β 2 -subunit isoforms.
Effects of 188-PSTP and 188-ASTA on L-type Ca 2+ and Ba 2+ currents
Equilibrium-binding experiments revealed that the highaffinity, two-site β 2 -subunit interaction previously reported for a longer C-terminal ahnak1 fragment [25] is fully conserved within the 188 C-terminal amino acids. The mutations of PSTP into ASTA left intact only the lower affinity site with a K d value around 1 µM, which is considered to be prone to physiological regulation. This interaction site was localised to the N-terminal portion of the Cavβ 2 including the SH3 domain [25] . Real-time SPRbinding measurements showed that both 188-PSTP and 188-ASTA associated rapidly with Cavβ 2 . Although SPR experiments revealed no significant higher affinity for 188-PSTP, in vitro binding approaches suggested that the C-terminal ahnak1 fragments could interfere with Cavβ 2 -regulated functions in cardiomyocytes. In fact, our patch clamp data clearly demonstrate that the ahnak1 fragments modify I CaL inactivation time course in rat and mouse cardiomyocytes, but not in ahnak1-deficient cardiomyocytes. These results are indicative for a complex interaction involving at least three partners: ahnak1 fragments, Cavβ 2 and endogenous ahnak1.
The increases in both inactivation time constants, over 50% in τ fast , led to significant increases in the amount of charges carried, Q Ca2+ . This observation is of physiological importance since most of Ca 2+ entry (> 75%) occurring during an action potential, particularly in rodents, is determined by the fast inactivation component of I Ca [6] . The modulation of I CaL inactivation by C-terminal ahnak1 fragments that leads to a 50-70% change in Q Ca2+ in the first 30 ms, should have important effects on excitation-contraction coupling gain during an action potential if one further takes into account the existence of Ca 2+ microdomains between the junctional sarcoplasmic reticulum and the Ttubular sarcolemma in which important increases in Ca 2+ would be expected even in response to small changes in Ca 2+ currents [6] . Inactivation of voltage-gated Ca 2+ channels that serve as a major source of Ca 2+ influx in excitable cells is precisely regulated. In the channel-forming α 1C subunit, the C-terminal binding site for the Ca 2+ sensor calmodulin appears essential for CDI as well as the loop connecting domains I and II is essential for voltage-dependent inactivation (VDI). The molecular mechanisms of VDI remain poorly understood although predominant contributions arise from the β-subunits (see below). At first glance, replacing extracellular Ca 2+ by Ba 2+ easily separates the two processes, although to some extent, CDI might result from a global change in intracellular tracings. Currents were normalized to maximal peak inward current. c, d
Voltage dependency of the inactivation time constants τ fast and τ slow in the same experimental conditions. n=9 WT and 9 KO, and 9 WT and 7 KO cardiomyocytes in control and PSTP, respectively, derived from at least four animals per group. * p<0.05 with respect to control Ca 2+ occurring after Ca 2+ release from internal stores [5] . Furthermore, VDI also exhibits fast and slow components [12, 13] which makes difficult to ascertain which one, CDI or fast VDI, predominates in the fast inactivation phase of I CaL with Ca 2+ as charge carrier. Interestingly, the CDI of Cav1.2 (cardiac L-type channel) and VDI of Cav2.1 (neuronal P/Q channel) are similarly regulated by the auxiliary β-subunit [7, 8] . Here, we report that in rat and WT mouse, 188-ASTA increases both τ fast and τ slow , but it neither shifts the voltage dependence of the kinetics nor alters the peak current amplitude. This increase in inactivation time constants is seen when using either Ca 2+ or Ba 2+ as the charge carrier. Furthermore, in the presence of 188-PSTP, our results are just opposite to what is expected from a τ fast -CDI paradigm since in rat cardiomyocytes, 188-PSTP increases peak I CaL but slows down τ fast [2] . When Ba 2+ equimolarly substitutes for Ca 2+ as charge carrier, both fast and slow inactivation time constants of I BaL are significantly increased by 188-PSTP and 188-ASTA. Under this condition, L-type current inactivation is mostly due to a two-component VDI, implying that ahnak1 fragments act mainly by modifying VDI through an interaction with the auxiliary β-subunit.
However, other possibilities, such as complex differential interactions of the permeating ion (Ca 2+ or Ba 2+ ) with the voltage sensor, cannot fully be ruled out [43] .
Impact of Cavβ isoforms for channel inactivation
The differential effects of Cavβ isoforms on VDI are well documented. For example, Cavβ 2a slows inactivation, whereas other Cavβ isoforms accelerates it. Distinct structural determinants have been reported in Cavβ to account for these opposite actions including lipid modification [9] , membrane attachment [45] and the GK domain [16] . The paradigm "membrane-bound β 2 splice variants slow inactivation" was particularly extended by Herzig et al. [24] , who showed that the degree of modulation correlates with the length of the amino-terminal domains of the β 2 splice variants in a manner that short N-termini (2a,b,e) slow inactivation while long N-termini (2c,2d) hasten inactivation. Of note recently, two different missense mutations in Cavβ 2b have been reported to cause accelerated Ca 2+ current inactivation underlying Brugada syndrome [3, 10] . In light of our results, ahnak1 fragment-induced slowing of I CaL could occur if that fragment applied through the patch tracings. Currents were normalized to maximal peak inward current. c, d
Voltage dependency of the inactivation time constants τ fast and τ slow in the same experimental conditions. n=8 WT and 8 KO, and 5 WT and 7 KO cardiomyocytes in control and ASTA, respectively, derived from at least four animals per group. * p<0.05 with respect to control pipette releases "slowing" Cavβ variants from endogenous ahnak1 and promotes their binding to I-II loop in Cav1.2 known to constitute the inactivating particle of the channel [39] . To this end, there are no data available whether ahnak1 prefers a certain Cavβ isoform. Future studies should address this issue. Alternatively, it can be envisioned that ahnak1 binding influences the accessibility of molecular determinants in Cavβ. Recently, Gonzalez-Gutierrez et al. [16] demonstrated that the GK domain present in all long Cavβ isoforms is the primary functional unit to slow I CaL inactivation, and masking this property allows for modulation. Although it is still a hypothesis, we propose that ahnak1 scaffolds Cavβ in cardiomyocytes. It may contribute to functional compartmentalisation of the various β-subunit isoforms identified in the heart [14, 22, 45] or may shape Cavβ subunits and thereby regulate the accessibility of molecular determinants. We found species-specific differences in β 2 -subunit isoform pattern between rat and mouse hearts that are in line with the structural determinants for modifying I CaL inactivation. In fact, I CaL inactivation was relatively slow in mouse cardiomyocytes (τ fast ∼ 13 ms) that showed a higher proportion of membrane-bound β 2 -subunits. The I CaL decay was very fast (τ fast ∼ 5 ms) in rat cardiomyocytes that expressed a longer, cytosolic β 2 -subunit isoform which likely represents the Cavβ 2c [28] . In both species, we found overabundance of β 2 -subunits compared to the channel forming α 1C , strengthening ahnak1 function as scaffold for Fig. 8 Expression of the Ca 2+ channel subunits α 1C and β 2 in ahnak1-deficient and nontransgenic cardiomyocytes. Western blot analyses demonstrating β 2 -subunit (a) and α 1C -subunit (b) protein levels in the total cardiac membrane protein fraction of ahnak1-KO and WT mice compared to recombinant β 2 -subunit (96 kDa) and α 1C _II-III loop (55 kDa). C Detection of β 2 -subunits in total heart proteins (30 µg) prepared from the rodent models as indicated (left panel) and in the rat heart cytosolic fraction before and after pull down with the α 1C _I-II loop (right panel) Cavβ 2 . The full-length ahnak1 molecule offers at least three attachment sites for the β 2 -subunit utilising ahnak1's proximal and distal C-terminus [17] .
Loss of I CaL modulation by ahnak1 fragments in ahnak1-deficient cardiomyocytes
In agreement with previous reports, the ahnak1-deficient mice were fertile and had no evident abnormalities [31, 32] . But cardiomyocytes isolated from ahnak1-KO mice showed morphological and functional alterations compared to sexand age-matched WT littermates. Ahnak1-deficient cardiomyocytes were smaller, particularly shorter consistent with the reduced cell capacitance. The reduction in cell length was not due to myocytes contraction as resting sarcomere distance was unaltered. Ahnak1-KO cardiomyocytes showed decreased I CaL density and faster I CaL inactivation kinetics. Reduced Ca 2+ influx through I CaL in ahnak1-deficient cardiomyocytes is in line with reports on ahnak1-deficient lymphocytes [35] and osteoblasts [42] , suggesting that ahnak1 promotes membrane expression of functional Ca 2+ channels. This conclusion is corroborated by unaltered voltage dependency of current-voltage relationship, activation and availability curves of I CaL in our KO myocytes.
The C-terminal ahnak1 fragments did not elicit any effects on I CaL characteristics in ahnak1-deficient cardiomyocytes. These findings exclude the possibility that 188-PSTP or 188-ASTA binds to endogenous β 2 -subunits or to any other site(s) and thereby influencing I CaL gating. Furthermore, the loss of I CaL modulation by ahnak1 fragments in ahnak1-deficient cardiomyocytes indicates that ahnak2 is not functional in this setting. Since ahnak2 lacks the C-terminal of ahnak1, it cannot compensate for the loss of function of ahnak1. In all ahnak1-expressing cardiomyocytes, including WT littermates, 3-month-old C57BL/6 mice (Alvarez, unpublished), 188-PSTP and 188-ASTA prolong I CaL inactivation time course; however, 188-PSTP mostly affected τ fast and only increased I CaL density in rat (present results; [2] ). Our binding experiments cannot explain the functional differences on I CaL between 188-PSTP and 188-ASTA. Apparently, cross-talk with distinct counteracting sites on endogenous ahnak1 is required to affect different aspects of I CaL gating.
Taken together, our results provide strong evidence for a nonredundant role of ahnak1 in the VDI of the cardiac L-type Ca 2+ channel. The findings imply that ahnak1 scaffolds Cavβ isoforms and suggest the ahnak1/Cavβ interactions as target for tuning Ca 2+ homeostasis in the heart.
